Cargando…

What is the ideal fibrinolysis to PCI time: Pharmaco-invasive strategy with streptokinase?

Detalles Bibliográficos
Autor principal:	Mishra, Sundeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650590/ https://www.ncbi.nlm.nih.gov/pubmed/29054177 http://dx.doi.org/10.1016/j.ihj.2017.07.022

Ejemplares similares

US Growth in PCI Care—Less than Ideal, but is the Ideal Less?
por: Bradley, Steven M., et al.
Publicado: (2013)

A Comparative Study of the Safety and Efficacy of Intrapleural Fibrinolysis With Streptokinase and Urokinase in the Management of Loculated Pleural Effusions
por: Saxena, Khushboo, et al.
Publicado: (2022)

Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach()()
por: Sultan, El-Zahraa M., et al.
Publicado: (2018)

Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible
por: Sharma, V
Publicado: (2018)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Pharmaco-genomics and anaesthesia: Mysteries, correlations and facts
por: Bhaskar, S Bala, et al.
Publicado: (2013)

Facilitated/Pharmaco-invasive Approaches in STEMI
por: Capodanno, Davide, et al.
Publicado: (2012)

Pharmaco‐Invasive Strategy: The Answer to Improving ST‐Elevation–Myocardial Infarction Care
por: Mentias, Amgad, et al.
Publicado: (2020)

Standardization of Coagulation and Fibrinolysis Methods
por: Jespersen, Jörgen
Publicado: (2000)

Introduction to the Special Issue of PharmacoEconomics on Major Depressive Disorders
por: Greenberg, Paul E., et al.
Publicado: (2021)

STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
por: ElGuindy, Ahmed M.
Publicado: (2014)

Clot Structure and Fibrinolysis in Thrombosis and Hemostasis
por: Bagoly, Zsuzsa, et al.
Publicado: (2017)

PCI or CABG, That is the Question!
por: Woo, Jong Shin, et al.
Publicado: (2017)

Pharmaco-prosthodontics revisited
por: Jagadeeshwaran, A. R., et al.
Publicado: (2012)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

PHYSICAL AND IMMUNOLOGICAL DIFFERENCES AMONG STREPTOKINASES
por: Dillon, Hugh C., et al.
Publicado: (1965)

Development of an Immunoaffinity Method for Purification of Streptokinase
por: Karimi, Zohreh, et al.
Publicado: (2012)

Streptokinase: Lack of efficacy: case report
Publicado: (2021)

Redefining successful primary PCI
por: McCartney, Peter J, et al.
Publicado: (2019)

Non-invasive cardiac output monitoring – To be or not to be, that is the question!
por: Gupta, Abhishek, et al.
Publicado: (2017)

Comparison of QT dispersion in patients with ST elevation acute myocardial infarction (STEMI) before and after treatment by streptokinase versus primary percutaneous coronary intervention (PCI)
por: Valizadeh, Abbas, et al.
Publicado: (2020)

CABG versus PCI: What is the optimal strategy for multi-vessel disease?
por: Kumar, Ayush, et al.
Publicado: (2022)

Heart attack guidance for physicians: When to suspect, how to diagnose, what to do?
por: Aggarwal, K.K., et al.
Publicado: (2017)

PHARMACO – THERAPEUTICS OF DASEMANI DRUGS
por: Sircar, N. N.
Publicado: (1984)

ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020)

Public reporting of PCI operator outcomes
por: Kelham, Matthew D., et al.
Publicado: (2019)

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry
por: Christ, Günter, et al.
Publicado: (2014)

Massive hemothorax following administration of intrapleural streptokinase
por: Chai, Feng Yih, et al.
Publicado: (2011)

Guillain-Barré Syndrome after Thrombolysis with Streptokinase
por: Okuyan, Ertugrul, et al.
Publicado: (2010)

Production and Purification of Streptokinase by Protected Affinity Chromatography
por: Babashamsi, Mohammad, et al.
Publicado: (2009)

Biosimilars: the process is the product. The example of recombinant streptokinase
por: Thelwell, C, et al.
Publicado: (2014)

Subacute Massive Pulmonary Embolism Treated With Streptokinase
por: Solanki, Naisargee N, et al.
Publicado: (2020)

EKG Criteria for Fibrinolysis: What’s Up with the J Point?
por: Brownfield, Joseph, et al.
Publicado: (2008)

Upscaling cardiac assist devices in decompensated heart failure: Choice of device and its timing
por: Mishra, Sundeep
Publicado: (2016)

From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
por: Bajcar, Jana M, et al.
Publicado: (2010)

Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value
por: Zoons, E., et al.
Publicado: (2012)

TCTAP A-014 Pharmacoinvasive Therapy in Treating Acute STEMI Patients in COVID-19 Era-Thrombolysis by Tenecteplase (TNK) / Streptokinase (STK) Followed by Rescue PCI of the Culprit Vessel
por: Islam, Ahm Waliul, et al.
Publicado: (2023)

Reperfusion Criteria in Patients Submitted to Fibrinolysis: Is There Room for Improvement?
por: Marcolino, Milena Soriano, et al.
Publicado: (2019)

The Ideal Physician
Publicado: (1892)

Before Coronary CTO PCI: Burden or Location?
por: Choi, Woong Gil
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69fd8n7aodrnbp072bn9h3rrbh